To initially establish the proof-of-principle of this approach, we took advantage of human cancer cell lines that carry a gain-of-function mutant PPM1D gene (the parental cell line; PPM1D+/mut), or the slower growing, derivative isogenic lines that carry only wild-type alleles (PPM1D+/+)16. This evidence concerns the gene PPM1D and cancer.